Our Leadership Team consists of accomplished Neuroscientists and Biopharmaceutical professionals with global experience.

Leadership Team

 

Max

Max S. Cynader, CM, OBC, PhD, FRSC, FCAHS.

CEO and Co-Founder

Professor, University of British Columbia (UBC). Canada Research Chair in Brain Development. Fellow, Canadian Academy of Health Sciences & Royal Society of Canada. Founder of 4 start-ups. Sold NeuroVir, a gene therapy products company, to treat brain cancer for $140M to Medigene AG in 2001.

Yu Tian

Yu Tian Wang, MD, PhD, FRSC.

CSO and Co-Founder

Professor, Department of Medicine & Centre for Brain Health, UBC. Holder of Heart & Stroke Foundation, BC & Yukon, Chair in Stroke Research. Fellow, Royal Society of Canada. Co-founder of NoNO Inc, a peptide therapeutics company. Peptide product successfully completed Phase 3.

Jack

Jack Jin, PhD.

Chief Operating Officer

PhD in Neuroscience, UBC. Over 10+ yrs in research. Inventor of several patents. Winner of many awards and honors. Key member of company since it was founded.

David

David Turner, CA

Chief Financial Officer

Over 30 yrs. of global experience in pharmaceuticals, medical devices, and other sectors. Built successful businesses from start-ups to companies with revenues of US$1 billion. Led or managed several successful IPO's on international Stock Exchanges. UK Chartered Accountant.

Julie

Julie Rezler, MA.

Vice President, Corporate Development

Over 15 yrs. experience in Life Sciences. Senior positions in 5 biopharma companies in US and Canada. Assisted in securing over $200M in public & private equity, plus multi-million dollar asset sales and M&A.

Janice

Janice Mallison, MSc

Vice President, Regulatory & Clinical Affairs

Over 30 yrs. experience in Regulatory & Clinical Affairs with 5 biopharma companies in US, Canada and EU. Deep expertise in liaising with FDA, EMA and Health Canada.

 

[ Leadership Team ] Advisory Boards ]